Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Beta‐carotene vs placebo

Neovascular AMD · general population

It is very uncertain whether beta‐carotene changes neovascular AMD compared with placebo (very low certainty).

1 finding from 1 review

Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration 2017 · Cochrane Headline outcomes only
RR 0.61 [0.17, 2.15]
1 study · 941 participants
Very low

Beta‐carotene vs placebo

Progression to late AMD (neovascular AMD, geographic atrophy or both) · general population

Beta‐carotene showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).

1 finding from 1 review

Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration 2017 · Cochrane Headline outcomes only
RR 0.9 [0.65, 1.24]
2 studies · 22083 participants
Moderate